BIOC-11 is under development for the treatment of bronchiectasis caused by Pseudomonas aeruginosa and cystic fibrosis. This candidate is formulated as an isotonic, buffered aqueous solution for oral ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
They also offer a game-changing solution to preserve last-resort treatments. Pseudomonas aeruginosa, a drug-resistant bacteria, is a major concern for doctors Enmetazobactam, developed by ...
According to federal health officials, the bacteria Pseudomonas aeruginosa was found "in multiple water samples between June 2021 to October 2022." CALIFORNIA FARM MAKES MASSIVE ORGANIC CARROT ...